Article Figures & Data
Tables
- TABLE 1
Genotype and phenotype comparison of Salmonella isolates from humans and retail meat, 2011 to 2013a
Antibiotic No. of test results Sensitivity (%) Specificity (%) PPV (%) NPV (%) Phenotype: resistant Phenotype: susceptible Genotype: resistant Genotype: susceptible Genotype: resistant Genotype: susceptible Aminoglycosides GEN 99 6 5 530 94.3 99.1 95.2 98.9 STR 257 3 35 345 98.8 90.8 88.0 99.1 Beta-lactam/beta-lactam inhibitor AMC 114 2 0 524 98.3 100.0 100 99.6 Cephems FOX 93 2 21 524 97.9 96.1 81.6 99.6 TIO 113 0 4 523 100.0 99.2 96.6 100 CRO 116 0 1 523 100.0 99.8 99.1 100 Penicillin AMP 241 1 1 397 99.6 99.7 99.6 99.7 Folate pathway inhibitors FIS 244 1 0 395 99.6 100.0 100 99.7 SXT 19 3 0 618 86.4 100.0 100 99.5 Macrolide AZM 1 0 0 639 100.0 100.0 100 100 Phenicol CHL 44 0 1 595 100.0 99.8 97.8 100 Quinolones CIP 4 0 0 636 100.0 100.0 100 100 NAL 13 2 0 625 86.7 100.0 100 99.7 Tetracycline TET 349 0 0 291 100.0 100.0 100 100 Total 1,707 20 68 7,164 98.8 99.1 96.2 99.7 ↵a Abbreviations: GEN, gentamicin; STR, streptomycin; AMC, amoxicillin-clavulanic acid; FOX, cefoxitin; TIO, ceftiofur; CRO, ceftriaxone; AMP, ampicillin; FIS, sulfisoxazole; SXT, trimethoprim-sulfamethoxazole; AZM, azithromycin; CHL, chloramphenicol; CIP, ciprofloxacin; NAL, nalidixic acid; TET, tetracycline; PPV, positive predictive value; NPV, negative predictive value.
Additional Files
Supplemental material
- Supplemental file 1 -
Table S1
XLSX, 98K
- Supplemental file 2 -
Table S2
XLSX, 69K
- Supplemental file 3 -
Table S3
XLSX, 12K
- Supplemental file 4 -
Table S4
XLSX, 12K
- Supplemental file 5 -
Table S5
XLSX, 35K
- Supplemental file 1 -